The world of beauty is a vibrant one, with perfumes and makeup symbolizing glamour, confidence, and self-expression .

Corporation, a biopharmaceutical company specializing in proprietary therapeutics with a market capitalization of $14 billion ...

In a turbulent market environment, AWH stock has tumbled to a 52-week low, reaching a price level of just $0.38. According to ...

The firm said it has received positive feedback from the FDA on the design of a Phase III trial of ELI-002 in KRAS-mutant pancreatic cancer.

Their study showed that DCIS patients with pathogenic variants in BRCA1/2 and PALB2 had a higher risk of developing invasive breast cancer than those without.

Mediar Therapeutics is planning to launch a Phase 2 clinical trial in the first half of 2025 to test its IPF therapy MTX-463.

Technologically the fast-changing world about healthcare is leaving no stone unturned An exciting development going on in it is the discovery of AI doctor and symptom checkers Today innovations on AI ...

The executive order’s definitions of male and female left room for interpretation contrary to the spirit of the order.

130 years after a fungus-eating plant received its name, a researcher has uncovered the purpose of the structure that inspired its name -- revealing a novel mechanism by which plants ensure ...

The executive order’s definitions of male and female left room for interpretation contrary to the spirit of the order.

Anixa Biosciences (NASDAQ:ANIX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at D. Boral Capital in a report released on Wednesday,Benzinga reports. They currently have ...